FDC Past Earnings Performance

Past criteria checks 5/6

FDC has been growing earnings at an average annual rate of 1.8%, while the Pharmaceuticals industry saw earnings growing at 13.3% annually. Revenues have been growing at an average rate of 10.7% per year. FDC's return on equity is 13.8%, and it has net margins of 15.3%.

Key information

1.8%

Earnings growth rate

3.0%

EPS growth rate

Pharmaceuticals Industry Growth17.5%
Revenue growth rate10.7%
Return on equity13.8%
Net Margin15.3%
Next Earnings Update12 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How FDC makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:531599 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2420,7233,1665,5740
30 Jun 2420,4483,1444,2440
31 Mar 2419,4293,0525,2190
31 Dec 2319,1572,8975,0750
30 Sep 2318,6682,5124,9910
30 Jun 2318,2552,3323,9860
31 Mar 2317,8381,9404,8900
31 Dec 2216,9001,7384,5510
30 Sep 2216,2251,6874,4210
30 Jun 2215,7511,8933,4910
31 Mar 2215,2792,1644,2680
31 Dec 2115,0032,5223,7590
30 Sep 2114,9872,9183,7340
30 Jun 2114,7253,0753,2350
31 Mar 2113,3323,0133,3530
31 Dec 2013,5313,1063,5050
30 Sep 2013,3413,0943,4030
30 Jun 2013,0892,7542,7570
31 Mar 2013,4422,3993,3440
31 Dec 1912,8152,1923,1290
30 Sep 1912,1651,9093,0130
30 Jun 1911,4421,7712,3430
31 Mar 1910,9071,6982,7720
31 Mar 1810,7511,7352,6770
31 Mar 1710,1391,8852,2490
31 Mar 169,9431,6872,0490
31 Mar 158,8931,4811,7060
31 Mar 148,4591,3532,1440

Quality Earnings: 531599 has high quality earnings.

Growing Profit Margin: 531599's current net profit margins (15.3%) are higher than last year (13.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 531599's earnings have grown by 1.8% per year over the past 5 years.

Accelerating Growth: 531599's earnings growth over the past year (26%) exceeds its 5-year average (1.8% per year).

Earnings vs Industry: 531599 earnings growth over the past year (26%) exceeded the Pharmaceuticals industry 22.3%.


Return on Equity

High ROE: 531599's Return on Equity (13.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 11:28
End of Day Share Price 2025/02/07 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

FDC Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCentrum Broking Limited
Kameswari V. S. ChavaliFirstCall Research